NDC 11523-7157-07 - Claritin Reditabs
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11523-7157
- Requested NDC
- 11523-7157-07
- Package NDCs from labels
- 11523-7157-2, 11523-7157-3, 11523-7157-4, 11523-7157-7, 11523-7157-8, 11523-7157-9, 11523-7157-07
- Manufacturer
- Bayer Healthcare LLC.
- Effective date
- 2025-12-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Claritin ® RediTabs ® | Bayer Healthcare LLC. | 2025-12-05 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11523-7157-2 | ClaritinReditabs | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | 12 | |
| 11523-7157-2 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-3 | ClaritinReditabs | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 12 | |
| 11523-7157-3 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-4 | ClaritinReditabs | 2 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 2 | 12 | |
| 11523-7157-4 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-7 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-7 | ClaritinReditabs | 4 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 4 | 12 | |
| 11523-7157-8 | ClaritinReditabs | 5 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 5 | 12 | |
| 11523-7157-8 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-9 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7157-9 | ClaritinReditabs | 7 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 7 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11523-7157 | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [BAYER HEALTHCARE LLC.] | 11 | Current NDC, Legacy NDC, 12 package rows | 20241208_b681ea25-d00b-4c8a-8054-cc6f983ce337.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 11523-7157-2 | EA - Each | 11523-7157 | 128f54a2-0776-4dea-a042-44b6442d3b69 | 1 | 2012-07-24 |
| 11523-7157-3 | EA - Each | 11523-7157 | fd89b497-47a4-4038-a766-17f963a2870b | 1 | 2012-07-24 |
| 11523-7157-8 | EA - Each | 11523-7157 | a461ab26-b1e4-4ea2-86d4-61841d1b15a0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Loratadine | ACTIVE INGREDIENT | 7AJO3BO7QN | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| Loratadine | ACTIVE MOIETY | 7AJO3BO7QN | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| gelatin | INACTIVE INGREDIENT | 2G86QN327L | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Claritin | LORATADINE | R J General Corporation | a34e8cb7-4fdf-45be-b288-45d93eef6220 | 2025-11-17 | Warnings | 7AJO3BO7QN |
| goodnow allergy relief | LORATADINE | Gobrands, Inc | 352a1268-7f44-417d-a46a-f0cc2e944a26 | 2025-11-15 | Warnings | 7AJO3BO7QN |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Childrens Loratadine Oral | LORATADINE | Major Pharmaceuticals | 3f0f0131-b516-4ff3-8049-3d3766324b66 | 2025-11-13 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | Aurobindo Pharma Limited | 4f4ffb72-f4e8-4617-8bc5-61e6de488a2d | 2025-11-12 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | A-S Medication Solutions | c84c2696-0d55-48a2-9d32-ca6c9bc57aa2 | 2025-11-11 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | A-S Medication Solutions | 26c19e5b-7288-41a2-baaf-b4af19630140 | 2025-11-10 | Warnings | 7AJO3BO7QN |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Loratadine | LORATADINE | A-S Medication Solutions | 0eade963-be64-4718-a370-7e78efb91fc4 | 2025-11-06 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | A-S Medication Solutions | 6f82e0ab-2c01-4afb-8d0f-b0c06819d1b0 | 2025-11-06 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | A-S Medication Solutions | 4cee60b6-b32b-47d0-aa00-a7ea1a7ed3cf | 2025-11-06 | Warnings | 7AJO3BO7QN |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| All Day Allergy Relief | LORATADINE | Family Dollar (FAMILY WELLNESS) | 6b8d786e-2ee3-487f-bf7b-7dc738ea2fc9 | 2025-10-29 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | Cabinet Health P.B.C. | 8b090fa2-9535-456c-b14d-187a2873cdf7 | 2025-10-27 | Warnings | 7AJO3BO7QN |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| McKesson Loradatine | LORATAINDE | McKesson Medical Surgical | c6a3056e-792e-52a4-e053-2a95a90a8361 | 2025-10-23 | Warnings | 7AJO3BO7QN |
| CVS Loratadine | LORATADINE | CVS Pharmacy | 3d716988-da63-59e6-e063-6394a90a5b4b | 2025-10-22 | Warnings | 7AJO3BO7QN |
| Walgreens Antacid Pain Relief Extra Strength | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walgreens | b60df498-07db-500b-e053-2a95a90aff6a | 2025-10-17 | Warnings | XF417D3PSL |
| Equate Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walmart | 6271b34b-55a0-40a8-e053-2a91aa0acb22 | 2025-10-17 | Warnings, Adverse reactions | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.